The historical rank and industry rank for Gossamer Bio's Days Sales Outstanding or its related term are showing as below:
GOSS's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 73.34 * Ranked among companies with meaningful Days Sales Outstanding only.
Gossamer Bio's Days Sales Outstanding
stayed the same
from Mar. 2023 (0.00) to Mar. 2024 (0.00).
Gossamer Bio Days Sales Outstanding Historical Data
The historical data trend for Gossamer Bio's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gossamer Bio's Days Sales Outstanding
For the Biotechnology subindustry, Gossamer Bio's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gossamer Bio's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gossamer Bio's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Gossamer Bio's Days Sales Outstanding falls into.
Gossamer Bio Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gossamer Bio (NAS:GOSS) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Gossamer Bio Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Gossamer Bio's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GOSS has been successfully added to your 